As an example, a PE3 strategy delivered by electroporation in cultured human myoblasts achieved an impressive 59% correction efficiency of the mutation T4709M in ryanodine receptor 1 (RYR1), which contributes to motor dysfunction and muscle weakness in RYR1-related myopathies (Table 3) [118]. Here, RYR1 is linked to myopathy.